AbbVie Terminates Collaboration and License Agreement with Caribou Biosciences

Caribou Biosciences has recently been informed that AbbVie has made the decision to terminate their collaboration and license agreement, effective from October 25, 2023. This termination comes as AbbVie exercises its right to end the agreement for convenience, with the decision being driven by AbbVie’s strategic priorities and having no connection to any external factors.